Extreme Movers: Muse Spark 1.1's picks for 2026-10-27
Muse Spark 1.1 picked SOFI, CLS, MRNA, INOD, XYL for a 1-day horizon. Average directional return: +8.27%. Directions called correctly: 100%.
| Experiment | Extreme Movers |
|---|---|
| Model | Muse Spark 1.1 |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-27 |
| Measured to | 2026-10-28 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +8.27% |
| Directions called correctly | 100% |
| Benchmark return | +0.58% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | SOFI | up | +5.43% | +5.43% | 70% | +4.86% | Yes |
| 2 | CLS | up | +4.57% | +4.57% | 68% | +3.99% | Yes |
| 3 | MRNA | up | +16.32% | +16.32% | 55% | +15.74% | Yes |
| 4 | INOD | down | -5.02% | +5.02% | 60% | +4.45% | Yes |
| 5 | XYL | down | -10.01% | +10.01% | 62% | +9.43% | Yes |
The model's market view
S&P 500 7,676.77 +0.71% and Nasdaq 26,169.38 +0.83% prior close per morning brief, sitting near record highs with futures flat, VIX 18.37, 10yr 4.986% and oil WTI 102.53 +1.73% ahead of OPEC+. Market is earnings-driven with 230 companies reporting Oct27 including Alphabet and Robinhood after close. Consumer Confidence at 10 ET is sole macro catalyst. Extreme movers are therefore stock-specific, with substantive Q3 beats guiding continuation and misses/downgrades prompting reversal or further downside.
Why each pick
SOFI
Top gainer +11.10% on Oct27 intraday leaderboard, ranked #6 on weeklytrader gainers table. Catalyst substantive: Q3 2026 beat and raised full-year outlook to USD 5.04B revenue reported by ChartMill at 08:47 ET Oct27, coverage initiation by Monness noted same day. Volume 53.36M vs 45.37M avg confirms institutional interest. Reference price 16.105 is live delayed intraday quote from finnhub on Oct27, not prior close, so freshness is ~minutes old at 10:02 ET open. Market cap 18.88B and avg dollar vol 1.28B USD (Average Daily Traded Value per finnhub) clear $1B/$20M floors. Continuation up thesis: guidance raise plus high beta 2.29 sustains momentum into next session; risk is profit-taking after 11% gap.
CLS
Ranked #11 gainer +10.22% Oct27 per weeklytrader. Catalyst substantive: Q3 revenue jumps 83% to USD 5.83B vs 3.19B year ago, GAAP EPS 3.26 vs 2.31, non-GAAP 3.30 beats consensus 2.93 by 0.37, and 2027 outlook USD 40B per Northern Current Oct27 08:54 and SeekingAlpha, AI hardware chain lifted by Philly Semi +2.82% best since Sep21. Reference price 274.77 is live finnhub quote Oct27, market cap 47.50B per finnhub (28.4B per MarketBeat, both >1B) and avg dollar vol ~546M from 2.21M avg shares * 247.03 price. Continuation up expected as outlook magnitude dominates free-cash-flow trim; risk is parabolic move already pricing beat and 5-day -9.56% drawdown before.
MRNA
Top loser -6.7639% per finnhub (-7.0% stockmarketwatch, -9.23% weeklytrader) Oct27. Catalyst speculative/valuation: William Blair downgrade on valuation after melanoma intismeran + Keytruda 42% risk reduction data scrutiny, target USD 250 ~26% below close per ad-hoc-news Oct27 14:12 CET. No new trial failure, stock up 60% past year and 528.69% YTD per finnhub. Reference price 185.4 live finnhub Oct27, market cap 79.89B, avg dollar vol ~3.94B from 19.84M avg vol * 198.85 price, avg vol 19.84M >20M dollar floor. Reversal up thesis: intraday washout oversold after downgrade, tickeron notes 50 of 62 prior 3-day declines bounced next month, high volume 17.07M vs 19.84M avg may signal capitulation; risk is continued rotation from high-beta biotech if yields hold near 5%.
INOD
Second biggest loser -21.33% per stockanalysis (-21.4155% finnhub) Oct27 with 1.4-1.7M volume vs 1.33M 20d avg. No company-specific news; catalyst speculative/profit-taking: stock slipped from low-mid $70s late Sep/early Oct after sharp rally, down 13.5% over 30 days per tickeron, trading at 35.7x forward earnings premium vs industry 26.7x per Zacks, EPS estimate cut to $1.01 from $1.12. Reference price 47.08 live finnhub Oct27, market cap 2.04B, avg dollar vol 94.75M USD Average Daily Traded Value per finnhub, price >$5. Continuation down thesis: breakdown below 30-day MA, high beta 3.04 and elevated short-term Sell indicators per Baxter, momentum selling persists into next session; risk is oversold bounce as AI data services story intact and earnings Nov5 approaching.
XYL
Loser -9.4882% per finnhub (-9.9% stockmarketwatch) Oct27. Catalyst substantive: Q3 earnings miss $1.44 vs $1.47 Zacks consensus and $1.45-1.46 consensus elsewhere, revenue $2.20B vs $2.28B miss $80M, and FY 2026 outlook cut to $8.95B with portfolio reset per SeekingAlpha 06:56 ET and ad-hoc-news Oct27. Shares tumbled 5.9% to $101.97 immediately after release per stockstory. Reference price 97.97 live finnhub Oct27, market cap 25.35B per finnhub (25.28B MarketBeat), avg dollar vol 234.1M USD Average Daily Traded Value per finnhub from 2.18M avg vol, both > floors. Continuation down thesis: double miss plus guidance cut typically extends selling next session as estimates revised; risk is support at 52-week low $98.58 and oversold pre-market $99.04 down 8.5% already.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Gemini 3 Pro | CLS, LITE, FICO, COHR, BE | +3.12% | 80% |
| Perplexity | NU, MELI, DASH, FIX, BE | -0.63% | 40% |
| Grok 4.7 | RRC, SGRY, XNCR, XP, FICO | +1.66% | 80% |
| Claude Sonnet 5.5 | NU, XP, TENB, RRC, FICO | +0.18% | 60% |
| DeepSeek | LITE, TSLA, FICO, COHR, DASH | +1.58% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Muse Spark 1.1's picks for 2026-10-27.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.